Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer

Androgen deprivation therapy (ADT) has been the standard care for patients with advanced prostate cancer (PC) since the 1940s. Although ADT shows clear benefits for many patients, castration-resistant prostate cancer (CRPC) inevitably occurs. In fact, with the two recent FDA-approved second-generati...

Full description

Bibliographic Details
Main Authors: Diane Ojo, Xiaozeng Lin, Nicholas Wong, Yan Gu, Damu Tang
Format: Article
Language:English
Published: MDPI AG 2015-11-01
Series:Cancers
Subjects:
prostate cancer
castration resistant prostate cancer
prostate cancer stem-like cells
androgen receptor
IL6
STAT3
Online Access:http://www.mdpi.com/2072-6694/7/4/0890

Similar Items

Similar Items